emergency-medicine
(3)
Cresilon Killed Its Big Launch - Then Built a Bleeding-Control Business the Hard Way
A 17-year-old's algae experiment became a syringe of hemostatic gel. The useful business lesson came later, when blackened batches forced Cresilon to cancel a launch and become its own manufacturer.
Inflammatix, Inc.
Inflammatix is a Sunnyvale, California molecular diagnostics company that reads the body's own immune response instead of hunting for the pathogen. Its FDA-cleared TriVerity test measures 29 host mRNAs from a blood sample and, using machine-learning algorithms, returns three scores in about 30 minutes: likelihood of bacterial infection, likelihood of viral infection, and overall illness severity. Run on the company's benchtop Myrna instrument, it is built for emergency and critical-care clinicians who need to decide fast whether a patient is heading toward sepsis. Spun out of Stanford in 2016, the company has raised more than $205M.
Vituity
Vituity is a 100% physician-owned and led multispecialty partnership delivering acute care across the United States. Founded in 1971 as California Emergency Physicians (CEP America), it rebranded as Vituity in 2018, combining 'vital' and 'acuity.' Today roughly 5,500 doctors and clinicians staff emergency departments, hospital medicine, critical care, anesthesiology, psychiatry, neurology, telehealth and more across hundreds of care sites in 27+ states, treating millions of patients a year - all without private equity, insurer, or hospital-system ownership.